What does Danicopan (Voydeya) do in plain English—and how does it work inside your body?
Danicopan is an FDA-regulated Complement Factor D Inhibitor (RxNorm RxCUI RXN-25682046-2315). Mechanistically, Pharmacologically, Danicopan functions within the Complement Factor D Inhibitor class via systemic delivery (Kit and 100 mg/1 Tablet, Film Coated), modulating target cellular receptors or enzymatic cascades while undergoing physiological hepatorenal clearance documented under FDA NDC 25682-046, 25682-043 (manufactured/labeled by Alexion Pharmaceuticals Inc.). [1][2].
When your doctor writes a prescription for Danicopan (RxNorm RxCUI RXN-25682046-2315, also dispensed under brand names including Voydeya), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Pharmacologically, Danicopan functions within the Complement Factor D Inhibitor class via systemic delivery (Kit and 100 mg/1 Tablet, Film Coated), modulating target cellular receptors or enzymatic cascades while undergoing physiological hepatorenal clearance documented under FDA NDC 25682-046, 25682-043 (manufactured/labeled by Alexion Pharmaceuticals Inc.). [2].
Across real-world patient logs on dotMD (86% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Danicopan tablet bottle and confirm with your pharmacist that it matches your prescribed strength (Kit, 100 mg/1 Tablet, Film Coated).